G2: Early Stage Pharma/Biotech Licensing

This workshop will focus on approaches and best practices when structuring early stage pharmaceutical and biotech IP deals in order to maximize value to both sides, including building in options and milestones, as well as considering the tax and financial reporting implications of legal entity structure.